Global Proteinase K Market: Overview
Proteinase K is a substrate from serine protease. Proteinase K is from stable S8 serine alkaline protease family groups containing one free cys and two disulfide bridges. It is used to digest proteins and eliminate contamination from the preparation of nucleic acid. These further inactivate nucleases that degrade DNA or RNA during the purification and isolation process. It determines the membrane's enzyme localization. It also digests the protein from the sample of brain tissue.
Global Proteinase K Market: Growth Factors
The proliferation of proteinase enzymes in the extraction of RNA and DNA for in-vitro examination and diagnosis is fueling the global proteinase K market growth. Proteinase K is used in the in-vitro examination due to its ability to remove the endotoxins which bind to lysozyme, ribonuclease A, and other cationic proteins. It also helps to isolate the mitochondria out of the hepatic cells and analyze enzyme localization over the membrane. It is used while antibody labeling in the treatment of paraffin-embedded segments of tissue.
All of these factors contribute to the growth of the global proteinase K market. Proteinase K assists in accurate detection of COVID-19 and thus, is expected to drive the market growth globally over the forecast period.
There is significant traction to use proteinase K via RT-qPCR because PCR is known to be the standard technology for COVID-19 detection.
Major explorations in the usage of proteinase K by healthcare professionals to unleash its potential to enhance the accuracy and quality of test results are likely to boost the market growth over the forecast period.
Global Proteinase K Market: Segmentation
The global proteinase K market can be segmented into therapeutic area, form, and region.
By therapeutic area, the market can be classified into neurology, autoimmune disease, nephrology, cardiology, oncology, diabetes, and infectious diseases.
Of these, the infectious disease holds the largest share in the global proteinase K market. The broad spectrum application of proteinase K in the examination and diagnosis of many infectious diseases is the major factor that fuels the proteinase K market globally. Proteinase K helps in the successful treatment of many infectious diseases. It assists in efficient DNA isolation and incubation from Hepatitis B virus with high yielding results.
Many studies say the DNA yield results by proteinase K are more efficient and reliable than the standard methods without the use of proteinase K.
The neurology segment is likely to grow with a significant increase in CAGR. The growth is attributed to the increased utilization of proteinase K in the diagnosis of prion diseases. The surge in adoption of this enzyme as an alternative to trypsin for efficient cross-linking studies is expected to drive the segment growth.
By form, the market can be segmented into powder and liquid.
The powdered form permits stock-based solutions as per the protocol requirements. Moreover, this powdered form holds a long shelf-life when compared to others.
Global Proteinase K Market: Regional analysis
North America holds the largest share in the global proteinase K market. The surge in the cases of cancer leads to growth in polymerase chain relation and next-generation sequence applications. These factors anticipate market growth in the coming years.
Asia Pacific is expected to witness a high growth rate over the forecast period due to the high cases of the coupled disorder.
China is expected to foresee high death rates due to cancer. This propels the regional market growth due to the increased utilization of proteinase K in the cancer biopsy specimen.
Constantly increasing COVID-19 cases are expected to boost the Asian market constantly due to the use of enzymes in COVID-19 detection.
Global Proteinase K Market: Competitive Players
Some of the significant leaders in the global proteinase K market are American Laboratories, Affymetrix, BBI Solutions, Dyadic International, Amicogen, Biocatalysts Ltd., Advanced Enzymes Technologies Ltd., Amano Enzyme Inc., F. Hoffmann-La Roche Ltd., Codexis, Inc., and Merck KGaA.
Global Proteinase K Market: Regional Segment Analysis
What Reports Provides